Translational analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)

被引：3
|
作者：
Tolcher, Anthony W.
Yap, Timothy A.
Plummer, Ruth
Grombacher, Thomas
Wang, Danyi
Schaffroth, Corinna
Hicking, Christine
Szucs, Zoltan
Locatelli, Giuseppe
de Bono, Johann S.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT271
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT271
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A phase I study of GW572016 in patients with solid tumors
    Minami, H
    Nakagawa, K
    Kawada, K
    Mukai, H
    Tahara, M
    Kurata, T
    Uejima, H
    Nogami, T
    Sasaki, Y
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 207S - 207S
  • [42] Phase I study of irinotecan in pediatric patients with malignant solid tumors
    Mugishima, H
    Matsunaga, T
    Yagi, K
    Asami, K
    Mimaya, J
    Suita, S
    Kishimoto, T
    Sawada, T
    Tsuchida, Y
    Kaneko, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 94 - 100
  • [43] Phase I study of pazopanib and ixabepilone in patients with solid tumors.
    Ganesan, Chitra
    Obulareddy, J.
    Bliss, Robin L.
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2013, 73 (08)
  • [44] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    Portnow, J.
    Frankel, P.
    Koehler, S.
    Twardowski, P.
    Shibata, S.
    Martel, C.
    Morgan, R.
    Cristea, M.
    Chow, W.
    Lim, D.
    Chung, V.
    Reckamp, K.
    Leong, L.
    Synold, T. W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 505 - 514
  • [45] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Haddad, Tufia
    Qin, Rui
    Lupu, Ruth
    Satele, Daniel
    Eadens, Matthew
    Goetz, Matthew P.
    Erlichman, Charles
    Molina, Julian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1221 - 1227
  • [46] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Kato, Shumei
    Adashek, Jacob J.
    Subbiah, Vivek
    Fu, Siqing
    Sun, Mianen
    Nguyen, Ly
    Brown, Elsa J.
    Yap, Timothy A.
    Karp, Daniel D.
    Piha-Paul, Sarina A.
    Hong, David S.
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 99 - 105
  • [47] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Tufia Haddad
    Rui Qin
    Ruth Lupu
    Daniel Satele
    Matthew Eadens
    Matthew P. Goetz
    Charles Erlichman
    Julian Molina
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1221 - 1227
  • [48] A phase I study of continuous infusion cilengitide in patients with solid tumors
    Peter H. O’Donnell
    Samir D. Undevia
    Walter M. Stadler
    Theodore M. Karrison
    M. Kelly Nicholas
    Linda Janisch
    Mark J. Ratain
    Investigational New Drugs, 2012, 30 : 604 - 610
  • [49] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Ciner, Aaron
    Gourdin, Theodore
    Davidson, Jeff
    Parette, Mylisa
    Walker, Susan J.
    Fox, Todd E.
    Jiang, Yixing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 23 - 29
  • [50] Phase I study of olaratumab in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Ma, Yan
    Dontabhaktuni, Aruna
    Nippgen, Cornelia
    Nippgen, Johannes
    Ohtsu, Atsushi
    CANCER SCIENCE, 2014, 105 (07) : 862 - 869
12345